Your session is about to expire
← Back to Search
Behavioral Intervention
Contingency Management for Cannabis Use in HIV
N/A
Recruiting
Led By Chukwuemeka N Okafor, PhD, MPH
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28-days
Awards & highlights
Study Summary
This trial will test the feasibility and impact of 28 days of abstinence from cannabis use on symptoms of depression and anxiety, pain, sleep, cannabis use withdrawal, HIV viral load and biomarkers of systemic inflammation among people with HIV who use cannabis regularly.
Who is the study for?
This trial is for people living with HIV who use cannabis at least weekly, can speak English, and are willing to try not using cannabis for 28 days while attending study visits. They must have a positive urine test for cannabis but cannot be seeking treatment for its use or have any major substance abuse disorders (except nicotine), psychiatric conditions, or other issues that could make the trial unsafe.Check my eligibility
What is being tested?
The study tests if giving money as motivation helps participants stop using cannabis for 28 days. It looks at how quitting affects their depression, anxiety, pain, sleep quality, withdrawal symptoms from stopping cannabis use, HIV viral load levels and inflammation markers in the body.See study design
What are the potential side effects?
Since this trial involves abstaining from cannabis rather than taking new medications, it does not list specific side effects like drug trials do. However, participants might experience withdrawal symptoms such as irritability or difficulty sleeping.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 28-days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28-days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Sustained cannabis abstinence for 28-days
Trial Design
1Treatment groups
Experimental Treatment
Group I: Contingency Management - CannabisExperimental Treatment1 Intervention
Participants will be incentivized following biochemical verification (from urine samples) of cannabis abstinence.
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center at San AntonioLead Sponsor
452 Previous Clinical Trials
91,369 Total Patients Enrolled
The University of Texas Health Sciences Center, HoustonUNKNOWN
National Institute on Drug Abuse (NIDA)NIH
2,468 Previous Clinical Trials
2,619,303 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I do not have a current alcohol or substance use disorder.You are currently using cannabis and are not willing to stop using it during the study.You have used cannabis at least once a week for the six months before agreeing to participate in the study.You are willing to stop using cannabis for 28 days and attend eight study visits over six weeks.You are able to speak and understand English well.You are currently being treated for addiction to drugs, including cannabis.I am currently diagnosed with or being treated for depression or anxiety.
Research Study Groups:
This trial has the following groups:- Group 1: Contingency Management - Cannabis
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Human Immunodeficiency Virus Infection Patient Testimony for trial: Trial Name: NCT04866004 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there vacancies for individuals to join this experiment?
"Affirmative, clinicaltrials.gov declares that this experiment is actively recruiting patients; it was launched on August 1st 2021 and edited lastly on February 28th 2022. The trial necessitates 45 volunteers from two separate healthcare establishments."
Answered by AI
How many participants is the research team recruiting for this trial?
"Affirmative. According to clinicaltrials.gov, this investigation is currently enrolling patients; it was initally posted on August 1st 2021 and most recently updated on February 28th 2022. 45 individuals need to be recruited across two medical centres."
Answered by AI
Who else is applying?
How old are they?
18 - 65
What site did they apply to?
Center for Neurobehavioral Research on Addiction
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
What state do they live in?
Texas
How many prior treatments have patients received?
1
0
Why did patients apply to this trial?
Interested in helping treatments evolve and get more information on objectives of study.
PatientReceived 2+ prior treatments
I've been pregnant while taking medication but still encountered problems with eating effectively and nausea.
PatientReceived 2+ prior treatments
What questions have other patients asked about this trial?
How long will the screenings be and dates?
PatientReceived 1 prior treatment
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger